| Date Filed | Type | Description |
| 08/15/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/11/2023 |
SC 13D/A
| RA CAPITAL MANAGEMENT, L.P. reports a 16.7% stake in 89BIO, INC. |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/23/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/25/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 04/24/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/24/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/14/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/27/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/24/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 0% stake in 89bio, Inc. |
| 03/22/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/22/2023 |
8-K
| Quarterly results |
| 03/15/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/10/2023 |
8-K
| Quarterly results |
| 02/27/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/22/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/14/2023 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 5.6% stake in 89bio, Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.4% stake in 89bio, Inc. |
| 02/14/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 8.3% stake in 89bio, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 6.5% stake in 89bio, Inc. |
| 02/10/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2023 |
8-K/A
| Quarterly results |
| 01/26/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 3.2% stake in 89bio, Inc. |
|